Info: 60 Veg. Capsules
Mushrooms have been used in a number of traditional medicine frameworks for aeons, of course, but they are increasingly gaining traction in Western medicine, as well, as they become the focus of modern research. AHCC (Active Hexose Correlated Compound) is a proprietary extract produced from the mycelia (the thread-like 'root' of a mushroom or its spores) of specially-cultivated and hybridized mushrooms in Japan, where it is a popular alternative medicine.
Some research suggests AHCC might be able to help prevent certain types of cancer brought on by HPV (human papillomavirus) infections, such as cervical cancer, anal cancer, and some types of oropharyngeal, vaginal, vulvar and penile cancer, since AHCC appears to be able to eradicate HPV. AHCC might also be able to increase Natural Killer (NK) cells' activities in fighting off infections and blocking tumour growth. There have also been animal studies showing it can help reduce the side effects or help the body respond to Candida albicans during chemotherapy. AHCC has also been shown to help support liver function, even among people with liver cancer.
Each capsule contains:
Proprietary Mushroom Mycelia Extract: 300 mg (from 500 mg AHCC Proprietary Blend)
Non-medicinal ingredients: Vegetable Capsule (hypromellose, water), Cellulose, Silica, Magnesium Stearate (vegetable source).
Suitable for vegetarians/vegans.
Suggested Usage:Adult Dosage: Take 2 capsules 3 times daily. Take with at least 240 ml liquid* (whether it's water, milk, fruit juice or a smoothie, etc.). Consult a health care practitioner for prolonged use.
Taking this product with insufficient liquid may result in choking and/or esophageal blockage/obstruction of the throat, esophagus or intestine.
Do not use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking doxorubicin or ondansetron. Nausea and diarrhea has been known to occur; in which case, discontinue use.
Health Canada Natural Product Number: 80034355.
Evaluation of active correlated compound (AHCC) for the Eradication of HPV Infections in Women with HPV positive Pap Smears. J.A. Smith. Pilot clinical trial at The University of Texas Health Science Center at Houston (UTHealth) Medical School. News Release, Oct 28, 2014.
Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H. Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice. J Exp Ther Oncol. 2009;8(1):43-51.